Study to Assess the Effect on Recovery of GI Motility and Safety and to Determine the Optimal Dose of LD02GIFRO
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01624571 |
|
Recruitment Status :
Completed
First Posted : June 20, 2012
Last Update Posted : February 27, 2013
|
Sponsor:
LG Life Sciences
Information provided by (Responsible Party):
LG Life Sciences
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | October 2012 |
| Actual Study Completion Date : | October 2012 |